TMPRSS2 and COVID-19: During the COVID-19 pandemic, it has been further demonstrated that SARS-CoV-2 can use CTSB and CTSL as well as TMPRSS2 for priming host cells (Hoffmann et al., 2020; Ou et al., 2020).